Poster Tour 6: Drug surveillance, harm reduction and priority populations
Tracks
.
| Tuesday, November 10, 2026 |
| 1:00 PM - 1:30 PM |
Speaker
APSAD 2026
Poster Tour 6: Introduction and Welcome
1:00 PM - 1:05 PMBiography
Kimberley Akrigg
Hdr Candidate
The University Of Queensland
Health Services Access and Harm Reduction Practices Among Women Who Use Image and Performance Enhancing Drugs: Findings from a Large International Sample
1:05 PM - 1:10 PMBiography
Kim Akrigg is an early career researcher at the University of Queensland with an interest in women's health and image and performance enhancing drugs.
Dr Jennifer Smith
Senior Research Fellow
University of Western Australia
What have we learned from five years of the Emerging Drugs Network of Australia, and how do we transition from a research-funded model to a sustainable toxicosurveillance system?
1:15 PM - 1:20 PMBiography
Jen is a Senior Research Fellow at the University of Western Australia and is the national coordinator of the Emerging Drugs Network of Australia (EDNA). Jen’s professional passion points and research experience are qualitative inquiry, evaluation methodology and harm reduction principles and practice.
Dr Shady Abdelsalam
Phd Candidate
National Drug Research Institute - Curtin University
Assessing the impact of the Medically Supervised Injecting Room (MSIR) on levels of oral health in a cohort of people who inject drugs.
1:25 PM - 1:30 PMBiography
Dr Shady Abdelsalam is a PhD candidate at NDRI, with a passion for oral health, public health and research. His PhD project is titled “The impact of medically supervised injecting room (MSIR) utilisation on health outcomes in people who inject drugs”.
